Incidence of Lyme disease in the UK: a population-based cohort study
- PMID: 31362975
- PMCID: PMC6677952
- DOI: 10.1136/bmjopen-2018-025916
Incidence of Lyme disease in the UK: a population-based cohort study
Abstract
Objectives: The purpose of this study was to estimate the annual incidence of Lyme disease (LD) in the UK.
Design: This was a retrospective descriptive cohort study.
Setting: Study data were extracted from the Clinical Practice Research Datalink (CPRD), a primary care database covering about 8% of the population in the UK in 658 primary care practices.
Participants: Cohort of 8.4 million individuals registered with general practitioners with 52.4 million person-years of observation between 1 January 2001 and 31 December 2012.
Primary and secondary outcome measures: LD was identified from recorded medical codes, notes indicating LD, laboratory tests and use of specific antibiotics. Annual incidence rates and the estimated total number of LD cases were calculated separately for each UK region.
Results: The number of cases of LD increased rapidly over the years 2001 to 2012, leading to an estimated incidence rate of 12.1 (95% CI 11.1 to 13.2) per 100 000 individuals per year and a UK total of 7738 LD cases in 2012. LD was detected in every UK region with highest incidence rates and largest number of cases in Scotland followed by South West and South England. If the number of cases has continued to rise since the end of the study period, then the number in the UK in 2019 could be over 8000. : Conclusions : The incidence of LD is about threefold higher than previously estimated, and people are at risk throughout the UK. These results should lead to increased awareness of the need for preventive measures.
Trial registration number: This study was approved by the Independent Scientific Advisory Committee for CPRD research (Protocol number 13_210R).
Keywords: epidemiology; incidence; lyme borreliosis; lyme disease.
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: CM, SR and CW are employees of the Institute for Epidemiology, Statistics and Informatics GmbH. The Institute for Epidemiology, Statistics and Informatics GmbH has received grants from Bayer, Bristol-Myers Squibb, CSL Behring and Merz Pharma outside the submitted work.
Figures
References
-
- Lindgren E, Jaenson TG. WHO Regional Office for Europe Copenhagen. Lyme borreliosis in Europe: influences of climate and climate change, epidemiology, ecology and adaptation measures (2006): WHO Regional Office for Europe Copenhagen. 2006. http://www.euro.who.int/document/E89522.pdf (Accessed 24 Jul 2018).
-
- Sykes RA, Makiello P. An estimate of Lyme borreliosis incidence in Western Europe†. J Public Health 2017;39:74–81. - PubMed
-
- Centers for Disease Control and Prevention. How many people get lyme disease? 2018.. https://www.cdc.gov/lyme/stats/humancases.html (Accessed 11 June 2019).
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials